Mineralys Therapeutics
MLYS
#6386
Rank
A$0.98 B
Marketcap
$19.72
Share price
4.31%
Change (1 day)
65.74%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$50.03 Million

According to Mineralys Therapeutics's latest financial reports the company's total liabilities are A$50.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mineralys Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.24 B421.61%
2021-12-31A$46.96 M610.49%
2020-12-31A$6.61 M